The key points of the initial discussion in the literature have focused on the issue of
equipoise in childrenbalancing risk and benefits for an individual child, which included …

In this, second of the two editorials on children and young people (CYP) in the COVID-19
pandemic, we focus on the complex discussion on vaccination of minors against severe …

In this, second of the two editorials on children and young people (CYP) in the COVID-19
pandemic, we focus on the complex discussion on vaccination of minors against severe …

The key points of the initial discussion in the literature have focused on the issue of
equipoise in childrenbalancing risk and benefits for an individual child, which included …

The key points of the initial discussion in the literature have focused on the issue of
equipoise in childrenbalancing risk and benefits for an individual child, which included …

In this, second of the two editorials on children and young people (CYP) in the COVID-19
pandemic, we focus on the complex discussion on vaccination of minors against severe …

In this, second of the two editorials on children and young people (CYP) in the COVID-19
pandemic, we focus on the complex discussion on vaccination of minors against severe …

pharmaceutical and biotechnological companies started testing the efficacy and safety of
vaccines in adolescents and children. CONSIDERATION OF INCLUSION OF CHILDREN …

The key points of the initial discussion in the literature have focused on the issue of
equipoise in childrenbalancing risk and benefits for an individual child, which included …